Yuanbao Inc. American Depositary Shares
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a YB research report →
Price Chart
About the company
Yuanbao Inc. , operating through its subsidiaries, manages an online platform for insurance distribution and various related services throughout the People's Republic of China. The company offers a diverse portfolio of insurance policies, including medical, critical illness, and life coverage.
- CEO
- Rui Fang
- IPO
- 2025
- Employees
- 613
- HQ
- Beijing, BE, CN
Get TickerSpark's AI analysis on YB
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $94.02M
- P/E
- 0.53
- Fwd P/E
- 0.39
- PEG
- -0.01
- P/S
- 0.12
- P/B
- 0.96
- EV/EBITDA
- -0.33
- Div Yield
- 10.49%
- Gross Margin
- 95.49%
- Op Margin
- 32.48%
- Net Margin
- 30.02%
- ROE
- 43.50%
- ROIC
- 23.83%
Latest fiscal year · YoY change
- Revenue
- $4.37B+33.1%
- Gross Profit
- $4.16B+33.6%
- Op Income
- $1.30B
- Net Income
- $1.27B+46.9%
- EPS
- $55.73-51.6%
- OCF Growth
- +23.8%
- FCF Growth
- +22.6%
- 52W High
- $24.40
- 52W Low
- $11.55
- 50D MA
- $13.21
- 200D MA
- $16.32
- Beta
- 0.54
- RSI (14)
- 42
- Avg Volume
- 32.23K
Earnings call summaries
Pick a quarter — each call distilled into takeaways, results, and a bull vs bear read.
Yuanbao posted another quarter of fast revenue and profit growth, while highlighting AI-led product upgrades, new advertising services, and continued shareholder returns.· September 10, 2026
- Revenue rose 30.1% year over year to RMB 1.39 billion, with net income up 35.6% to RMB 413.2 million.
- Insurance distribution revenue increased 30.4% to RMB 457.4 million, while system services revenue rose 22.8% to RMB 881.9 million.
- A new advertising services revenue stream contributed RMB 52.8 million in the quarter, but management said it was still a small share of revenue.
- Cash and investments totaled RMB 5.16 billion at quarter-end, and operating cash flow was RMB 419.1 million.
- Management said the USD 15 million share repurchase program is progressing, with about 114,000 ADSs repurchased for roughly USD 1.6 million by August 31.
Total revenue was RMB 1.39 billion, up 30.1% year over year. Insurance distribution services revenue was RMB 457.4 million, up 30.4% year over year; system services revenue was RMB 881.9 million, up 22.8% year over year; and advertising services revenue was RMB 52.8 million. Total operating costs and expenses were RMB 941.3 million, up 21.9% year over year. Net income was RMB 413.2 million, up 35.6% year over year, with a net income margin of 29.7%; non-GAAP adjusted net income was RMB 431.2 million, up 32.6% year over year, with a margin of 31%. Cash and cash equivalents, time deposits, restricted cash and short-term investments totaled RMB 5.16 billion, up 50.9% year over year and 8.8% sequentially, and operating cash flow was RMB 419.1 million. For forward commentary, management did not provide formal numeric guidance, but said it expects to keep pursuing high-quality growth, operational efficiency, and a healthy liquidity position; it also said dividends should be maintained or grown subject to profitability and cash flow, and the USD 15 million buyback program may be expanded or adjusted depending on execution.
The CEO emphasized that Yuanbao is combining policy tailwinds, product innovation, and AI to broaden access to commercial health insurance. He highlighted upgrades to the Super Medical Insurance series, new products for people with pre-existing conditions, and expanded AI use across user insights, recommendations, and claims assistance. His tone was confident and strategic, repeatedly framing the company as positioned to benefit from the high-quality development of China’s health insurance market.
The CFO focused on strong top-line growth, margin discipline, and a strong balance sheet. He cited the key figures: revenue of RMB 1.39 billion, operating costs and expenses of RMB 941.3 million, net income of RMB 413.2 million, adjusted net income of RMB 431.2 million, and cash/investments of RMB 5.16 billion; he also noted operating cash flow of RMB 419.1 million. He said advertising services were newly launched this quarter, while higher operations and support costs were mainly tied to that new business, and he reiterated a disciplined capital allocation approach balancing investment, liquidity, and shareholder returns.
Analysts focused on three themes: online marketing compliance, the new advertising business, and the impact of AI on customer acquisition and claims. Management said the new regulation on online financial-product marketing had not materially affected its model because it already has a compliance review system and works through licensed carriers; it also said celebrity live-streaming is just a traffic entry point, while the real moat is product matching, data, and ecosystem synergy. On AI, management said its vertical AI tools are still early but already improve claims processing, citing 95% material classification accuracy, about 94% key field extraction accuracy, and a 41% reduction in settlement time for small claims under RMB 10,000; it also said the Hong Kong brokerage business had no new update.
The call showed strong revenue and profit growth alongside healthy cash generation, suggesting the core business is still scaling well. Management also sounded optimistic about AI-enabled efficiency gains, new product innovation for pre-existing-condition and critical-illness coverage, and policy support for commercial health insurance.
Management acknowledged some pressure from heavier external traffic competition and said ROI can be diluted as ad spend expands into new segments. The new advertising business is still small and management would not disclose details on its medium-term margins or pricing trends, while the AI and agentic-commerce opportunities are described as early-stage and not yet sufficient to support a full insurance purchase journey.
AI summary of the company's earnings call · Paraphrased · Not investment advice
- Free Float
- 13.9%
- Shares Outstanding
- 7.68M
- Float Shares
- 1.07M
of shares held by institutions
17 13F filers
Buy/sell ratio 0.80. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Susquehanna International Group, Llp | 3.04M | 0 |
| Franchise Gp Ltd | 1.21M | ▲ 680.76K |
| Lighthouse Investment Partners, LLC | 153.22K | ▲ 60.67K |
| Point72 Asset Management, L.P. | 104.70K | ▼ 10.79K |
| Franchise Capital Ltd | 66.67K | 0 |
| Barclays PLC | 62.32K | ▲ 2.86K |
| Morgan Stanley | 39.99K | ▼ 1.71K |
| Millennium Management LLC | 35.32K | ▲ 35.32K |
| Jpmorgan Chase & Co | 19.31K | ▼ 4.73K |
| Citadel Advisors LLC | 19.23K | ▲ 19.23K |
| Xtx Topco Ltd | 13.69K | ▲ 13.69K |
| Jane Street Group, LLC | 13.29K | ▲ 13.29K |
Held by 2 ETFs
Biggest fund positions in YB by dollar value.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Sep 16, 26 | Wang Bo Ethan | other | 1,280 |
| Sep 16, 26 | Han Xu Harley | other | 1,037 |
| Sep 16, 26 | Sun Shuli | other | 815 |
| Sep 24, 26 | Yue Ying | other | 42,000 |
| Sep 24, 26 | Yue Ying | other | 7,000 |
| Sep 24, 26 | Yue Ying | sell | 2,866 |
| Sep 16, 26 | Yue Ying | other | 815 |
| Sep 16, 26 | Li Ying Dana | other | 4,363 |
| Sep 16, 26 | WAN HUI RUI | other | 436 |
| Sep 24, 26 | Fang Rui | other | 5,700 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our YB coverage
Recent articles, reports, and earnings notes.
No research on YB yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate YB report →Citizens (NYSE:CIA) vs. Yuanbao (NASDAQ:YB) Head to Head Review
defenseworld.net · Oct 6
Yuanbao (NASDAQ:YB) Reaches New 52-Week Low – Time to Sell?
defenseworld.net · Oct 1
Yuanbao: Still Worth Hanging On To
seekingalpha.com · Sep 12
Yuanbao: Bullish On Earnings Growth Acceleration And Dividend Commitment
seekingalpha.com · Sep 11
Yuanbao Inc. (YB) Q2 2026 Earnings Call Transcript
seekingalpha.com · Sep 10
Yuanbao Q2 Earnings Call Highlights
marketbeat.com · Sep 10
Yuanbao Inc. Announces Second Quarter 2026 Unaudited Financial Results
globenewswire.com · Sep 10
Yuanbao Inc. to Announce Second Quarter 2026 Financial Results on Thursday, September 10, 2026
globenewswire.com · Sep 3
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.